Schuler- Pancreatic Pathology Flashcards
in the _____ state there is Low insulin / high glucagon
fasting
in the ____ state there is high insulin/low glucagon
fed state
either not enough insulin produced or end up with tissues insensitive with insulin secretion
diabetes
GLUT receptor on beta cell
GLUT2
what happens when glucose comes into beta cell
lots of ATP produced
K+ channel closes (no efflux)
Ca2+ influx
insulin secretion
____ phase of insulin secretion: insulin secretion in abundance in response to high blood glucose
fed state
1st
____ phase of insulin secretion: prolonged phase, largely independent of blood glucose
2nd
_____need glucose to survive to perform metabolic processes
tissues
DM - low insulin/ low C-peptide
type I DM
normal or high insulin and C-peptide
type 2 DM
low C-peptide / high insulin
Excessive exogenous insulin
high C-peptide / high insulin
Insulinoma
drug that increases tissue specific insulin sensitivity; and one of the mechanisms by which they do this is increasing the translocation of GLUT4 transporters to cell membrane
Metformin
glucose transporter found in kidneys
SGLT2
glucose transporter found in intestines
SGLT1
pancreatic beta cells have what 2 glucose transporters
GLUT1 and GLUT2
hepatocytes have what 2 glucose transporters
GLUT1 and GLUT2
CNS haas what glucose transporter
GLUT3
skeletal muscle, cardiac muscle, adipose tissue has what glucose transporter that is insulin-dependent
GLUT4
lipogenesis at adipose tissue and liver
glycogen synthesis at liver and muscle
(by what)
insulin
Secreted by GI tract due to a meal
Slows down gastric emptying, and gives body more time to use substrates (pt stays full longer)
why pts lose weight
And increases insulin sensitivity in target cells
GLP-1 (incretin) agonists
incretin effect is significantly blunted in type 2 DM, so administering exogenous _____ is incredibly helpful
GLP-1
abnormal glucose metabolism resulting in hyperglycemia and dyslipidemia
diabetes mellitus
million Americans age 18 and older had prediabetes & are at high risk for developing frank diabetes
96